Saturday - September 20, 2025
State Tipoffs Involving Alabama Newsletter for Friday January 05, 2024 ( 4 items )  

MCDERMOTT WILL & EMERY REPRESENTS GRUPO MEXICO TRANSPORTES IN 60% EQUITY STAKE ACQUISITION FROM GENESEE & WYOMING, SEACOR HOLDINGS
CHICAGO, Illinois, Jan. 5 -- McDermott Will and Emery, a law firm, issued the following news release: International law firm McDermott Will & Emery represented Grupo Mexico Transportes (GMXT) in the acquisition of a 60% equity stake from Genesee & Wyoming Inc. (G&W) and SEACOR Holdings Inc. (SEACOR) of: * The joint venture that owns and operates CG Railway, a company that provides 4-day rail-ferry service between the ports of Mobile, Alabama, and Coatzacoalcos, Veracruz, across the Gulf of Mex  more

Troy University: William H. Carr School of Accountancy is Well Represented in National Accounting Organization
TROY, Alabama, Jan. 4 -- Troy University issued the following news: TROY alumnus Boyd Busby (BS, Acct. '99) has been appointed to the board of directors of the National Association of State Boards of Accountancy. Busby serves as the executive director liaison on the board and will chair its Executive Director Committee. He currently is the director of the Alabama State Board of Public Accountancy, a post to which he was appointed in 2015. He also serves on NASBA's Experience, Learn & Earn and  more

UNA Alum Awarded Presidential Lifetime Achievement Award
FLORENCE, Alabama, Jan. 4 -- The University of North Alabama issued the following Q&A on Jan. 3, 2024, with student Evan Oglesby: * * * University of North Alabama alum Evan Oglesby was recently awarded the Joseph R. Biden Lifetime Achievement Award and Presidential Volunteer Service Award for his contributions through the Evan Oglesby (EO) Foundation. The ceremony took place at the Ebenezer Baptist Church in Atlanta. Oglesby is a 2007 graduate of the Sanders College of Business and Technolo  more

University of Alabama: An Enhanced Brain Delivery of Antibodies Heightens the Potential to Treat Brain Diseases
BIRMINGHAM, Alabama, Jan. 4 (TNSres) -- The University of Alabama issued the following news: By Jeff Hansen The blood-brain barrier blocks the entry of antibodies into the brain. This limits the potential use of antibody therapeutics to treat brain diseases, such as brain tumors. Elsewhere in the body, more than 100 United States Food and Drug Administration-approved therapeutic antibodies are used by medical teams to treat cancers and autoimmune, infectious and metabolic diseases. Finding wa  more